The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal Cancers

卷:12

Review

关键词: HELICOBACTER-PYLORI INFECTION;    TUMOR-ASSOCIATED MACROPHAGES;    PANCREATIC STELLATE CELLS;    GENE-EXPRESSION SIGNATURE;    SQUAMOUS CARCINOMA-CELLS;    REGULATED ONCOGENE GRO;    FACTOR-KAPPA-B;    HEPATOCELLULAR-CARCINOMA;    GASTRIC-CANCER;    DUFFY ANTIGEN;   

DOI  :  10.3390/cells12101406

来源: SCIE

【 摘 要 】

One area of cancer research is the interaction between cancer cells and immune cells, in which chemokines play a vital role. Despite this, a comprehensive summary of the involvement of C-X-C motif ligand 1 (CXCL1) chemokine (also known as growth-regulated gene-a (GRO-a), melanoma growth-stimulatory activity (MGSA)) in cancer processes is lacking. To address this gap, this review provides a detailed analysis of CXCL1's role in gastrointestinal cancers, including head and neck cancer, esophageal cancer, gastric cancer, liver cancer (hepatocellular carcinoma (HCC)), cholangiocarcinoma, pancreatic cancer (pancreatic ductal adenocarcinoma), and colorectal cancer (colon cancer and rectal cancer). This paper presents the impact of CXCL1 on various molecular cancer processes, such as cancer cell proliferation, migration, and invasion, lymph node metastasis, angiogenesis, recruitment to the tumor microenvironment, and its effect on immune system cells, such as tumor-associated neutrophils (TAN), regulatory T (T-reg) cells, myeloid-derived suppressor cells (MDSCs), and macrophages. Furthermore, this review discusses the association of CXCL1 with clinical aspects of gastrointestinal cancers, including its correlation with tumor size, cancer grade, tumor-node-metastasis (TNM) stage, and patient prognosis. This paper concludes by exploring CXCL1's potential as a therapeutic target in anticancer therapy.